Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

GLTOGLTO
1 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in DAMORA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 166,347 shares of GLTO (DAMORA THERAPEUTICS INC), worth $4.3M as of 2026-Q2. This is a new position. GLTO represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$4.3M

Current Shares

166,347

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
166,347
-
$4.3M0.0%$28.08
37

Other major holders of GLTO: FMR LLC, Avoro Capital Advisors LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used